Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative effectiveness questions in oncology.

× No keyword cloud information.

15 in total

Review 1. Efficient design of clinical trials and epidemiological research: is it possible?

Authors: Michael S Lauer; David Gordon; Gina Wei; Gail Pearson
Journal: Nat Rev Cardiol Date: 2017-04-27 Impact factor: 32.419

Review 2. Drug repurposing in oncology--patient and health systems opportunities.

Authors: Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal: Nat Rev Clin Oncol Date: 2015-10-20 Impact factor: 66.675

3. Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States.

Authors: Zhiyuan Zheng; Xuesong Han; Gery P Guy; Amy J Davidoff; Chunyu Li; Matthew P Banegas; Donatus U Ekwueme; K Robin Yabroff; Ahmedin Jemal
Journal: Cancer Date: 2017-02-20 Impact factor: 6.860

4. Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.

Authors: Won Kim; Li Zhang; John H Wilton; Gerald Fetterly; James L Mohler; Vivian Weinberg; Allison Morse; Russell Z Szmulewitz; Terence W Friedlander; Lawrence Fong; Amy M Lin; Andrea L Harzstark; Arturo Molina; Eric J Small; Charles J Ryan
Journal: Clin Cancer Res Date: 2014-10-21 Impact factor: 12.531

Review 5. The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors: Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal: Nat Rev Clin Oncol Date: 2017-03-14 Impact factor: 66.675

6. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Authors: Teppei Matsumoto; Shingo Hatakeyama; Teppei Ookubo; Koji Mitsuzuka; Shintaro Narita; Takamitsu Inoue; Shinichi Yamashita; Takuma Narita; Takuya Koie; Sadafumi Kawamura; Tatsuo Tochigi; Norihiko Tsuchiya; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama
Journal: Med Oncol Date: 2017-10-31 Impact factor: 3.064

7. Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).

Authors: Hope S Rugo; William T Barry; Alvaro Moreno-Aspitia; Alan P Lyss; Constance Cirrincione; Eleanor Leung; Erica L Mayer; Michael Naughton; Deborah Toppmeyer; Lisa A Carey; Edith A Perez; Clifford Hudis; Eric P Winer
Journal: J Clin Oncol Date: 2015-06-08 Impact factor: 44.544

Review 8. Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists.

Authors: Salvatore Patanè
Journal: World J Cardiol Date: 2015-05-26

9. Workflow Differences Affect Data Accuracy in Oncologic EHRs: A First Step Toward Detangling the Diagnosis Data Babel.

Authors: Franck Diaz-Garelli; Roy Strowd; Virginia L Lawson; Maria E Mayorga; Brian J Wells; Thomas W Lycan; Umit Topaloglu
Journal: JCO Clin Cancer Inform Date: 2020-06

10. Economic analysis of not running tenders for recombinant Factor VIII procurement: a simplified analysis to estimate an otherwise unknown pharmacoeconomic index.

Authors: Dario Maratea; Valeria Fadda; Sabrina Trippoli; Andrea Messori
Journal: Eur J Hosp Pharm Date: 2015-12-23